+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Forecast 2023-2030- Product Image
Global Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Forecast 2023-2030- Product Image
Sale

Global Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Forecast 2023-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5914462
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cystatin C Assay Market size was estimated at USD 396.25 million in 2022, USD 427.47 million in 2023, and is expected to grow at a CAGR of 7.32% to reach USD 697.41 million by 2030.

The cystatin C assay is a laboratory test utilized to measure the levels of cystatin C, a protein produced by nearly all cells in the body. It is most useful in exceptional cases where creatinine measurement could be misleading. The increasing prevalence of kidney diseases and the growing geriatric population drive the need for cystatin C assay. Furthermore, the increasing availability and clinical adoption of cystatin C with the introduction of advanced automated testing methods have led to its market growth. In contrast, the high manufacturing costs of cystatin C assays and strict interpretation guidelines restrict their adoption. However, several vendors are investing in R&D to overcome its issues. Furthermore, advancements in diagnostics technologies, emerging research, and ongoing publishing of clinical guidelines for cystatin C assay provide substantial market growth opportunities.

Regional Insights

In North America, particularly in the U.S., the presence of major healthcare and diagnostic companies, research institutions, and well-established healthcare infrastructure is a significant contributor to the cystatin C assay market. Moreover, stringent regulatory standards laid by government regulatory agencies, including the U.S. Food and Drug Administration (FDA) and Health Canada, play a crucial role in product approvals for cystatin c assay. In South America, increasing awareness about the importance of early disease diagnosis and a growing healthcare sector is expected to contribute to the expanding need for cystatin C assay. In Europe, countries such as Germany, France, Switzerland, and the United Kingdom are contributing to the growing adoption of cystatin C assay as they have well-established healthcare infrastructure with high spending and a focus on technological advancements in the pharmaceutical and biotechnology sectors. In the Middle East and Africa, the growing prevalence of chronic diseases with increasing population and a focus on improving diagnostic capabilities with investing heavily in the healthcare sector is expected to bolster the usage of cystatin C assay in the region. In APAC countries, including China and Japan, the increasing number of geriatric residents and the rising prevalence of chronic diseases contribute to the expansion of the market. In countries including China, India, and Australia, increasing awareness of kidney diseases and proactive health screening initiatives by government and regional healthcare companies increase the need for diagnostic tests such as cystatin c assay. In emerging nations such as Indonesia, Thailand, and Vietnam, economic development, expanding healthcare access, and an emphasis on preventive healthcare support the application of cystatin C assay in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cystatin C Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cystatin C Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cystatin C Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abbott Laboratories, Abcam PLC, Advy Chemical Pvt. Ltd., Agilent Technologies, Inc., AOBIOUS Inc., Arbor Assays Inc., Aviva Systems Biology Corporation, BBI Solutions OEM Limited, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biorbyt Ltd, BioVendor – Laboratorní medicína a.s., Boditech Med Inc., Cepham Life Sciences, Inc., Cusabio Technology LLC, DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc. by General Atomics, Eagle Biosciences, Inc., Elabscience Biotechnology Inc., Ethos Biosciences, Inc., Eurolyser Diagnostica GmbH by Mars, Incorporated, F. Hoffmann-La Roche Ltd, Fapon Biotech Inc., Fortress Diagnostics Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., ImmunoDiagnostics Limited, Kamiya Biomedical Company, Laboratory Corporation of America Holdings, Merck KGaA, Proteintech Group, Inc., PZ CORMAY S.A., Randox Laboratories Ltd., RayBiotech, Inc., Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sino Biological, Inc., Thermo Fisher Scientific Inc., Tosoh Corporation, Weldon Biotech, and Zhejiang Kangte Biotechnology Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Cystatin C Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Analyzer
    • Kits
    • Reagents
  • Method
    • Chemiluminescence Immunoassay
    • Enzyme linked Immunosorbent Assay
    • Immunofluorescence Assay
    • Particle-enhanced Nephelometric Immunoassay
    • Particle-enhanced Turbidimetric Immunoassay
  • Sample Type
    • Blood
    • Urine
  • Setting
    • Laboratory Setting
    • Point of Care Setting
  • Application
    • Diagnosis Use
    • Research & Development
  • End-user
    • Academic Research Centers
    • Diagnostic Laboratories
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cystatin C Assay Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cystatin C Assay Market?
  3. What are the technology trends and regulatory frameworks in the Cystatin C Assay Market?
  4. What is the market share of the leading vendors in the Cystatin C Assay Market?
  5. Which modes and strategic moves are suitable for entering the Cystatin C Assay Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cystatin C Assay Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of kidney diseases and growing geriatric population
5.1.1.2. Progressive investments in healthcare infrastructures for renal disorders
5.1.2. Restraints
5.1.2.1. High development costs of cystatin C assays and incidences of product recalls
5.1.3. Opportunities
5.1.3.1. Advances in cystatin C assay testing
5.1.3.2. Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
5.1.4. Challenges
5.1.4.1. Dearth of skilled lab professionals and technical challenges associated with cystatin C assay
5.2. Market Segmentation Analysis
5.2.1. Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions
5.2.2. Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays
5.2.3. Setting: Expanding usage of point-of-care setting for cystatin C assays
5.2.4. Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample
5.2.5. Application: Increasing application of cystatin C assays for diagnosis of renal function
5.2.6. End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers
5.3. Market Trend Analysis
5.3.1. Well-established healthcare infrastructure coupled with emphasis on commercializing Cystatin C Assay solutions in the Americas
5.3.2. Supportive government programs to reduce the burden of renal disorders in the Asia-Pacific region
5.3.3. Growing focus on developing and expanding novel cystatin C assays products in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cystatin C Assay Market, by Product
6.1. Introduction
6.2. Analyzer
6.3. Kits
6.4. Reagents
7. Cystatin C Assay Market, by Method
7.1. Introduction
7.2. Chemiluminescence Immunoassay
7.3. Enzyme linked Immunosorbent Assay
7.4. Immunofluorescence Assay
7.5. Particle-enhanced Nephelometric Immunoassay
7.6. Particle-enhanced Turbidimetric Immunoassay
8. Cystatin C Assay Market, by Sample Type
8.1. Introduction
8.2. Blood
8.3. Urine
9. Cystatin C Assay Market, by Setting
9.1. Introduction
9.2. Laboratory Setting
9.3. Point of Care Setting
10. Cystatin C Assay Market, by Application
10.1. Introduction
10.2. Diagnosis Use
10.3. Research & Development
11. Cystatin C Assay Market, by End-user
11.1. Introduction
11.2. Academic Research Centers
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
12. Americas Cystatin C Assay Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Cystatin C Assay Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Cystatin C Assay Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
15.3.1. Agreement, Collaboration, & Partnership
15.3.1.1. Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
15.3.1.2. Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
15.3.1.3. Gentian Diagnostics ASA Signs Distribution Agreement for Cystatin C
15.3.2. New Product Launch & Enhancement
15.3.2.1. Bloom Diagnostics Launches New Kidney Test
15.3.3. Investment & Funding
15.3.3.1. Jana Care Raises USD 6 Million for Commercialisation of Self-Administered Blood Tests
15.3.3.2. Renalyse Closes a EUR 1 Million Funding Round with the Participation of GENESIS Ventures
15.3.4. Award, Recognition, & Expansion
15.3.4.1. LordsMed Announces the Launch of its First Pathology Centre in Maharashtra
15.3.4.2. New European Cystatin C Equation for eGFR May Be More Accurate
16. Competitive Portfolio
16.1. Key Company Profiles
16.1.1. Abbexa Limited
16.1.2. Abbott Laboratories
16.1.3. Abcam PLC
16.1.4. Advy Chemical Pvt. Ltd.
16.1.5. Agilent Technologies, Inc.
16.1.6. AOBIOUS Inc.
16.1.7. Arbor Assays Inc.
16.1.8. Aviva Systems Biology Corporation
16.1.9. BBI Solutions OEM Limited
16.1.10. Bio-Rad Laboratories, Inc.
16.1.11. Bio-Techne Corporation
16.1.12. Biorbyt Ltd
16.1.13. BioVendor - Laboratorní medicína a.s.
16.1.14. Boditech Med Inc.
16.1.15. Cepham Life Sciences, Inc.
16.1.16. Cusabio Technology LLC
16.1.17. DIALAB GmbH
16.1.18. DiaSys Diagnostic Systems GmbH
16.1.19. Diazyme Laboratories, Inc. by General Atomics
16.1.20. Eagle Biosciences, Inc.
16.1.21. Elabscience Biotechnology Inc.
16.1.22. Ethos Biosciences, Inc.
16.1.23. Eurolyser Diagnostica GmbH by Mars, Incorporated
16.1.24. F. Hoffmann-La Roche Ltd
16.1.25. Fapon Biotech Inc.
16.1.26. Fortress Diagnostics Ltd.
16.1.27. Gentian Diagnostics ASA
16.1.28. Getein Biotech, Inc.
16.1.29. ImmunoDiagnostics Limited
16.1.30. Kamiya Biomedical Company
16.1.31. Laboratory Corporation of America Holdings
16.1.32. Merck KGaA
16.1.33. Proteintech Group, Inc.
16.1.34. PZ CORMAY S.A.
16.1.35. Randox Laboratories Ltd.
16.1.36. RayBiotech, Inc.
16.1.37. Sekisui Diagnostics, LLC
16.1.38. Siemens Healthineers AG
16.1.39. Sino Biological, Inc.
16.1.40. Thermo Fisher Scientific Inc.
16.1.41. Tosoh Corporation
16.1.42. Weldon Biotech
16.1.43. Zhejiang Kangte Biotechnology Co., Ltd.
16.2. Key Product Portfolio
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. CYSTATIN C ASSAY MARKET RESEARCH PROCESS
FIGURE 2. CYSTATIN C ASSAY MARKET SIZE, 2022 VS 2030
FIGURE 3. CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 4. CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 6. CYSTATIN C ASSAY MARKET DYNAMICS
FIGURE 7. CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 9. CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
FIGURE 10. CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 11. CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2030 (%)
FIGURE 12. CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 13. CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2022 VS 2030 (%)
FIGURE 14. CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 15. CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 16. CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 17. CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 18. CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 19. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 21. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 22. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 23. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD THOUSAND)
FIGURE 27. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 28. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. CYSTATIN C ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 5. CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 6. CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 7. CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 8. CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 9. CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 10. CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 11. CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 12. CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 13. CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 14. CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 15. CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 16. CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 17. CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 18. CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 19. CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 20. CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 21. CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 22. CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 23. CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 24. CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 25. CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 26. CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 27. CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 28. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 29. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 30. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 31. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 32. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 33. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 34. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 35. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 36. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 37. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 38. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 39. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 40. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 41. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 42. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 43. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 44. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 45. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 46. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 47. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 48. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 49. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 50. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 51. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 52. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 53. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 54. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 55. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 56. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 57. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 58. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 59. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 60. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 61. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 62. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 63. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 64. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 65. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
TABLE 66. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 67. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 68. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 69. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 70. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 71. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 72. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 73. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 74. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 75. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 76. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 77. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 78. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 79. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 80. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 81. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 82. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 83. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 84. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 85. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 86. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 87. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 88. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 89. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 90. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 91. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 92. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 93. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 94. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 95. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 96. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 97. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 98. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 99. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 100. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 101. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 102. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 103. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 104. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 105. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 106. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 107. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 108. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 109. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 110. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 111. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 112. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 113. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 114. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 115. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 116. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 117. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 118. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 119. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 120. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 121. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 122. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 123. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 124. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 125. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 126. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 127. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 128. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 129. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 130. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 131. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 132. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 133. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 134. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 135. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 136. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 137. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 138. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 139. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 140. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 141. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 142. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 143. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 144. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 152. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 153. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 154. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 155. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 156. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 157. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 158. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 159. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 160. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 161. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 162. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 163. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 164. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 165. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 166. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 167. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 168. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 169. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 170. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 171. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 172. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 173. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 174. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 175. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 176. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 177. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 178. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 179. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 180. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 181. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 182. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 183. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 184. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 185. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 186. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 187. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 188. ITALY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 189. ITALY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 190. ITALY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 191. ITALY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 192. ITALY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 193. ITALY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 194. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 195. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 196. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 197. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 198. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 199. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 200. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 201. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 202. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 203. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 204. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 205. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 206. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 207. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 208. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 209. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 210. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 211. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 212. POLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 213. POLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 214. POLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 215. POLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 216. POLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 217. POLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 218. QATAR CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 219. QATAR CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 220. QATAR CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 221. QATAR CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 222. QATAR CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 223. QATAR CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 224. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 225. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 226. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 227. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 228. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 229. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 230. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 231. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 232. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 233. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 234. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 235. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 236. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 237. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 238. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 239. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 240. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 241. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 242. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 243. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 244. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 245. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 246. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 247. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 248. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 249. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 250. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 251. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 252. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 253. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 254. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 255. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 256. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 257. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 258. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 259. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 260. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 261. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 262. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 263. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 264. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 265. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 266. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 267. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 268. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 269. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 270. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 271. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 272. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
TABLE 273. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
TABLE 274. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
TABLE 275. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
TABLE 276. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
TABLE 277. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 278. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 279. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 280. CYSTATIN C ASSAY MARKET LICENSE & PRICING

Companies Mentioned

  • Abbexa Limited
  • Abbott Laboratories
  • Abcam PLC
  • Advy Chemical Pvt. Ltd.
  • Agilent Technologies, Inc.
  • AOBIOUS Inc.
  • Arbor Assays Inc.
  • Aviva Systems Biology Corporation
  • BBI Solutions OEM Limited
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biorbyt Ltd
  • BioVendor – Laboratorní medicína a.s.
  • Boditech Med Inc.
  • Cepham Life Sciences, Inc.
  • Cusabio Technology LLC
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc. by General Atomics
  • Eagle Biosciences, Inc.
  • Elabscience Biotechnology Inc.
  • Ethos Biosciences, Inc.
  • Eurolyser Diagnostica GmbH by Mars, Incorporated
  • F. Hoffmann-La Roche Ltd
  • Fapon Biotech Inc.
  • Fortress Diagnostics Ltd.
  • Gentian Diagnostics ASA
  • Getein Biotech, Inc.
  • ImmunoDiagnostics Limited
  • Kamiya Biomedical Company
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Proteintech Group, Inc.
  • PZ CORMAY S.A.
  • Randox Laboratories Ltd.
  • RayBiotech, Inc.
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • Sino Biological, Inc.
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Weldon Biotech
  • Zhejiang Kangte Biotechnology Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 427.47 Million
Forecasted Market Value ( USD ) by 2030 $ 697.41 Million
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned43

Related Topics

Related Reports

Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories) & Region - Global Forecast to 2028 - Product Image

Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories) & Region - Global Forecast to 2028

  • Report
  • 263 Pages
  • Global
From
Cystatin C Assay Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Cystatin C Assay Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Cystatin C Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Cystatin C Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 173 Pages
  • Global
From
Global Cystatin C Assay Market: Focus on Applications, End Users, Types, Methods, Sample and Over 14 Countries' Data - Analysis and Forecast, 2024-2033 - Product Image

Global Cystatin C Assay Market: Focus on Applications, End Users, Types, Methods, Sample and Over 14 Countries' Data - Analysis and Forecast, 2024-2033

  • Report
  • 151 Pages
  • Global
From
2024 World Immunoassay Analyzers and Reagents in 98 Countries - Supplier Shares and Competitive Analysis, 2023-2028 - Product Image

2024 World Immunoassay Analyzers and Reagents in 98 Countries - Supplier Shares and Competitive Analysis, 2023-2028

  • Report
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.